Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 20 01 2021
revised: 12 07 2021
accepted: 13 07 2021
pubmed: 8 8 2021
medline: 3 3 2022
entrez: 7 8 2021
Statut: ppublish

Résumé

To clarify the incidence and risk factors of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in pediatric patients with febrile status epilepticus (FSE). We retrospectively surveyed patients with FSE (≥20 min and ≥40 min) who were younger than 6 years by mailing a questionnaire to 1123 hospitals in Japan. The survey period was 2 years. We then collected clinical data on patients with prolonged febrile seizures (PFS) ≥40 min and those with AESD, and compared clinical data between the PFS and AESD groups. The response rate for the primary survey was 42.3%, and 28.0% of hospitals which had applicable cases responded in the secondary survey. The incidence of AESD was 4.3% in patients with FSE ≥20 min and 7.1% in those with FSE ≥40 min. In the second survey, a total of 548 patients had FSE ≥40 min (AESD group, n = 93; PFS group, n = 455). Univariate analysis revealed significant between-group differences in pH, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, creatine kinase, NH Incidence data and prediction scores for AESD will be useful for future intervention trials for AESD.

Identifiants

pubmed: 34362595
pii: S0387-7604(21)00132-7
doi: 10.1016/j.braindev.2021.07.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Informations de copyright

Copyright © 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures Study funding: This work was supported by scholarship grants for M. Matsuo from Otsuka Pharmaceutical Co., Ltd. and Shionogi & Co., Ltd. The other authors declare no competing interests.

Auteurs

Fumio Ichinose (F)

Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan. Electronic address: fumio.ichinose@gmail.com.

Takuji Nakamura (T)

Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan; Department of Pediatrics, National Hospital Organization Ureshino Medical Center, Saga, Japan.

Ryutaro Kira (R)

Department of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.

Kenji Furuno (K)

Department of General Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Shigeki Ishii (S)

Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.

Kazunari Takamura (K)

Department of Pediatrics, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.

Marina Hashiguchi (M)

Department of Pediatrics, Japan Organization of Occupational Health and Safety, Yokohama Rosai Hospital, Kanagawa, Japan.

Takushi Inoue (T)

Department of Pediatrics, National Hospital Organization Okayama Medical Center, Okayama, Japan.

Ayako Senju (A)

Department of Pediatrics, Kitakyushu General Hospital, Fukuoka, Japan.

Yuko Ichimiya (Y)

Department of Pediatrics, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Takafumi Sakakibara (T)

Department of Pediatrics, Nara Medical University, Nara, Japan.

Nobuyoshi Sugiyama (N)

Department of Pediatrics, School of Medicine, Tokai University, Kanagawa, Japan.

Tomomi Naitou (T)

Department of Pediatrics, Saiseikai Kawaguchi General Hospital, Saitama, Japan.

Naoya Higuchi (N)

Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan; Department of Pediatrics, Saga Prefectural Medical Center Koseikan, Saga, Japan.

Masami Togawa (M)

Department of Pediatrics, Tottori Prefectural Central Hospital, Tottori, Japan.

Ken-Ichi Torii (KI)

Department of Pediatrics, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.

Soichiro Toda (S)

Department of Pediatrics, Kameda Medical Center, Chiba, Japan.

Hiroko Iwamatsu (H)

Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan.

Tatsuharu Sato (T)

Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan.

Satoshi Tsurui (S)

Department of Pediatrics, Seirei Numazu Hospital, Shizuoka, Japan.

Hidenori Tanaka (H)

Department of Pediatrics, Komaki City Hospital, Aichi, Japan.

Mitsuo Motobayashi (M)

Department of Pediatric Neurology, Nagano Children's Hospital, Nagano, Japan.

Akiko Abe (A)

Department of Pediatrics, Yamagata City Hospital Saiseikan, Yamagata, Japan.

Atsushi Kawaguchi (A)

Education and Research Center for Community Medicine, Saga University, Saga, Japan.

Muneaki Matsuo (M)

Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH